In a 34-year-old man with right inner‑thigh pain and a large inflamed subcutaneous inguinal lymph node measuring 5.3 × 3.6 × 2.7 cm on CT, what is the recommended initial diagnostic and therapeutic approach?

Immediate Fine-Needle Aspiration Biopsy of the Enlarged Inguinal Lymph Node

In this 34-year-old man with a 5.3 cm inflamed inguinal lymph node, you must obtain tissue diagnosis immediately via ultrasound-guided fine-needle aspiration cytology (FNAC) or core needle biopsy to differentiate between malignant and inflammatory causes. 1

Initial Diagnostic Approach

Urgent Tissue Sampling

The size of this lymph node (5.3 cm) places it in the category requiring immediate pathological confirmation. For palpable inguinal nodes, FNAC biopsy and/or histology is the recommended first-line diagnostic approach 1. The guidelines are explicit: when nodes are palpable, lymph node metastases can be diagnosed using percutaneous FNAC biopsy 1.

If the initial FNAC is negative but clinical suspicion remains high, proceed immediately to repeat biopsy or surgical node excision 1. This is critical because approximately 70% of palpable inguinal nodes in certain malignancies represent true metastatic disease 2.

Critical Physical Examination Details to Document

Record the following specific characteristics:

• Exact dimensions (already documented: 5.3 × 3.6 × 2.7 cm)
• Mobility versus fixation to surrounding structures
• Skin involvement or ulceration
• Bilateral versus unilateral presentation
• Number of palpable nodes in both groins
• Presence of leg, scrotal, or penile edema 3, 2

Essential Workup Based on Primary Pathology

If malignancy is confirmed on FNAC:

1. Search for the primary tumor systematically:

   • Examine the entire penis, glans, and external genitalia for any lesions
   • Inspect the lower extremity skin for melanoma or squamous cell carcinoma
   • Examine the perineum and perianal region
   • In males, consider penile cancer as inguinal nodes are the primary drainage site 1

2. Staging imaging immediately:

   • PET-CT scan is the preferred modality for detecting pelvic lymph node metastases and distant disease in patients with confirmed inguinal node involvement 1
   • If PET-CT unavailable: CT chest/abdomen/pelvis 1

If inflammatory/infectious etiology suspected or confirmed:

1. Consider tuberculosis in the differential, especially with caseous necrosis on histology—obtain T-SPOT.TB or interferon-gamma release assay 4
2. Culture for bacterial pathogens if abscess or suppurative lymphadenitis
3. Trial of antibiotics (4-6 weeks) only if infection strongly suspected, but do not delay biopsy 3

Critical Pitfall to Avoid

Do not treat empirically with antibiotics without tissue diagnosis in a node this large. While historically, palpable lymphadenopathy was treated with prophylactic antibiotics to reduce inflammatory enlargement, current guidelines emphasize that this approach delays definitive diagnosis and adversely impacts survival when malignancy is present 2. At diagnosis, approximately 50% of palpable inguinal nodes are enlarged due to inflammatory changes, but nodes that become palpable during follow-up are malignant in nearly 100% of cases 1.

Therapeutic Algorithm Based on Biopsy Results

If Squamous Cell Carcinoma (Penile Primary):

• Inguinal lymph node dissection (ILND) is indicated for confirmed metastatic disease 3, 5
• For nodes ≥4 cm or bulky disease: consider neoadjuvant chemotherapy (paclitaxel, ifosfamide, cisplatin) followed by surgical resection 5
• Pelvic lymph node dissection if pelvic nodes involved on imaging 1

If Melanoma:

• Evaluate for extracapsular spread and rounded morphology on CT—these predict need for ilioinguinal versus inguinal-only dissection 6
• Consider sentinel lymph node biopsy of contralateral groin if unilateral disease

If Lymphoma:

• Excisional biopsy may be needed for definitive subtyping
• Systemic staging with PET-CT
• Oncology referral for chemotherapy 7

If Infectious/Inflammatory:

• Targeted antimicrobial therapy based on culture results
• For tuberculosis: standard 6-month anti-tuberculous therapy 4

The key principle: tissue diagnosis drives all subsequent management decisions, and a 5.3 cm node demands immediate pathological evaluation, not empiric treatment.